Porton to Showcase End-to-End CDMO Expertise at CPHI Milan 2026

CPHI Milan, the world's premier pharmaceutical trade show, will take place from October 6–8, 2026, at Fiera Milano (Rho), Milan, Italy. As the most influential flagship event in the global pharmaceutical and manufacturing industry, CPHI Milan 2026 is expected to gather over 62,000 attendees, 2,400+ exhibiting companies, and 180+ speakers from more than 166 countries. CPHI creates connections and inspires partnerships across the global pharma community, championing innovation at the heart of pharma through in-person and online events that grant access to endless opportunities.

Porton Pharma Solutions will proudly showcase its integrated CDMO capabilities at Booth 10K6. As an End-to-End CDMO companies, Porton will present its customized R&D and GMP manufacturing services to pharmaceutical and biotech clients, as well as research institutions worldwide, spanning the entire drug lifecycle from pre-clinical development to commercialization. Our capabilities cover both drug substances (APIs) and drug products across multiple modalities, including Small Molecules, TIDES, Biologics and Conjugates (ADCs, AOCs, DACs, PDCs, RDCs, etc.), and Advanced Therapy Medicinal Products. As of June 30, 2026, Porton had over 4,400 employees globally, built partnerships with more than 1,500 customers, and successfully delivered approximately 6,000 projects. Porton is committed to empowering global clients with efficient, high-quality custom R&D and manufacturing solutions, facilitating seamless translation from preclinical research to commercial launch.

At this year's event, our scientists and global business development team will be on-site to engage with industry leaders, explore the latest trends and developments in pharmaceuticals, and co-create the future of drug innovation.

For onsite meeting appointments, please contact us via:

• Visit the offline meeting section on Porton's official website

• Email: business@portonpharma.com